Project ALS
Non-Profit & Charitable Organizations · New York, United States · <25 Employees
View Company Info for Free
About
Headquarters
801 Riverside Dr Apt 6G, New York City, New Yor...Phone Number
(212) 420-7382Website
www.projectals.orgRevenue
<$5 MillionIndustry
Most Recent Scoops
Highlights
<$5M
Total Funding Amount
<$5M
Most Recent Funding Amount
1
Number of Funding Rounds
Who is Project ALS
Project ALS Org Chart
Is Project ALS your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Check out if Project ALS is spiking on competitors!
Check if Project ALS has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Project ALS has new funding data
Click to see if Project ALS had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Project ALS
Project ALS, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Project ALS recently announced quarterly report
Product Launch: Get notified when Project ALS launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Project ALS as Masked Content
Find 2 more new buyers
Compare Similar Companies to Project ALS
Compare insights from companies similar to Project ALS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Project ALS
Project ALS financials insights
Gather financial insights about Project ALS, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Project ALS Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Project ALS Tech Stack
A closer look at the technologies used by Project ALS
Project ALS News & Media
ProJenX launches to advance novel, targeted therapies for ALS and other brain diseases
NEW YORK, Feb. 16, 2022 /PRNewswire/ -- ProJenX, a New York City-based, clinical-stage biotechnology company developing novel, brain-penetrant therapies targeting biologically-defined pathways for the treatment of amyotrophic lateral sclerosis (ALS) and other debilitating brain diseases,...Project ALS Announces Research Advisory Board 2.0
NEW YORK, Oct. 20, 2021 /PRNewswire/ -- Project ALS, a non-profit 501(c)3 leader in the pursuit of treatments and a cure for the neurodegenerative disease ALS, has announced its research advisory board (RAB). Non-Profit ALS Research Leader Gathers a Diversity of Expertise to Guide...Project ALS Granted FDA Orphan Drug Designation for Prosetin for the Treatment of Amyotrophic Lateral Sclerosis
NEW YORK, Sept. 4, 2020 /PRNewswire/ -- Project ALS, a non-profit 501(c)3 organization that funds research toward the first meaningful treatments for amyotrophic lateral sclerosis (ALS), announced today that the Food and Drug Administration (FDA) has granted orphan drug designation to...Medidata Institute and Project ALS Launch Partnership to Accelerate New Treatment Strategies
NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes company, and the global leader in creating end-to-end solutions supporting the entire clinical trial process, announced the launch of a research partnership between the Medidata Institute and Project ALS. The program is designed to gain a greater understanding of the ALS disease process and develop new therapeutic strategies. The Medidata Institute engages and partners with research organizations, life science companies, researchers, regu
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Project ALS
Project ALS is a non-profit 501(c)3 that identifies and funds the most promising scientific research that will lead to the first effective treatments and a cure for ALS. The Project ALS Pre-Clinical Core at Columbia University is supported by generous donations from the Kleiner Family Research Initiative, Stu and Leslie Hendel, Team Chris Combs, an... Read More